Ameriprise’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$675K Buy
105,887
+2,595
+3% +$18.1K ﹤0.01% 3462
2025
Q4
$727K Sell
103,292
-40,946
-28% -$247K ﹤0.01% 3480
2025
Q3
$793K Buy
144,238
+66,074
+85% +$324K ﹤0.01% 3461
2025
Q2
$404K Buy
78,164
+58,721
+302% +$352K ﹤0.01% 3599
2025
Q1
$129K Buy
19,443
+7,645
+65% +$58.1K ﹤0.01% 3845
2024
Q4
$87K Buy
+11,798
New +$84.7K ﹤0.01% 3964
2021
Q3
Sell
-18,776
Closed -$525K 3905
2021
Q2
$525K Buy
+18,776
New +$496K ﹤0.01% 3444

Other funds holding LFST

Ameriprise's LFST Position: Q1 2026 in Review

Ameriprise increased its Lifestance Health (LFST) stake by 2.5% in Q1 2026, buying an estimated $18.1K and bringing the position to 105,887 shares worth $675K. The position accounts for ﹤0.01% of the portfolio, ranked #3462.

Ameriprise first reported a position in LFST in Q2 2021 and has held it in 7 quarters since. The position peaked at $793K in Q3 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Ameriprise held 105,887 shares of Lifestance Health worth $675K as of Q1 2026.
  • Ameriprise bought 2,595 Lifestance Health shares in Q1 2026, an estimated $18.1K.
  • Lifestance Health made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3462 holding.
  • Ameriprise first reported a position in Lifestance Health in Q2 2021 and has held it in 7 quarters since.
  • Ameriprise's Lifestance Health position peaked at $793K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.